InspireMD (NSPR) Net Margin Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 322,004.00 |
| Sep 30, 2025 | -29,330.00 |
| Jun 30, 2025 | 6,011.00 |
| Mar 31, 2025 | -55,405.00 |
| Dec 31, 2024 | 114,420.00 |
| Sep 30, 2024 | -24,707.00 |
| Jun 30, 2024 | -31,206.00 |
| Mar 31, 2024 | 28,210.00 |
| Dec 31, 2023 | -5,463.00 |
| Sep 30, 2023 | -10,090.00 |
| Jun 30, 2023 | -21,923.00 |
| Mar 31, 2023 | -11,635.00 |
| Dec 31, 2022 | 18,470.00 |
| Sep 30, 2022 | -2,596.00 |
| Jun 30, 2022 | 5,563.00 |
| Mar 31, 2022 | 7,095.00 |
| Dec 31, 2021 | 41,072.00 |
| Sep 30, 2021 | 4,526.00 |
| Jun 30, 2021 | 2,251.00 |
| Mar 31, 2021 | 7,763.00 |
| Dec 31, 2020 | -180,006.00 |
| Sep 30, 2020 | 35,213.00 |
| Jun 30, 2020 | -22,620.00 |
| Mar 31, 2019 | -37,007.00 |
| Sep 30, 2018 | -732.00 |
| Jun 30, 2018 | 89,338.00 |
| Mar 31, 2018 | 8,542.00 |
| Dec 31, 2017 | -51,197.00 |
| Sep 30, 2017 | 118,413.00 |
| Mar 31, 2017 | -17,381.00 |
| Dec 31, 2016 | -6,712.00 |
| Sep 30, 2016 | -31,042.00 |
| Jun 30, 2016 | -14,364.00 |
| Mar 31, 2016 | -28,760.00 |
| Dec 31, 2015 | -38,930.00 |
| Sep 30, 2015 | -50,685.00 |
| Jun 30, 2015 | -49,311.00 |